Press release
Diabetic Neuropathy Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Diabetic Neuropathy Market Share
What Is the Expected Diabetic Neuropathy Market Size During the Forecast Period?
The market scale for diabetic neuropathy has seen a significant expansion in the past few years. Its growth is projected to rise from $5.79 billion in 2024 to $6.27 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.3%. Several factors have contributed to this upward trajectory during the historic period, including increasing global incidence of diabetes, heightened awareness and diagnosis, advancements in diabetic treatment, expanding healthcare spending, research and development funding, and initiatives dedicated to patient education.
It is projected that the market size for diabetic neuropathy will experience swift expansion in the coming years, reaching a value of $9.3 billion in 2029. This growth represents a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this development during the predicted period include progression in neuroimaging, patient-focused care methods, growth in clinical trials, an ongoing increase in diabetes cases, precision medicine practices, development in regenerative medicine, along with patient advocacy and assistance programs. Key trends projected for this period encompass joint endeavors in medical investigation, digital health advancements, improvements in diagnostic technologies, neuroprotective treatments, personalized therapeutic strategies, and the incorporation of artificial intelligence.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9057
What Are the High-Growth Segments in the Diabetic Neuropathy Market?
The diabetic neuropathy market covered in this report is segmented -
1) By Disorder: Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy
2) By Drug Class: Analgesics, Anti-Depressants, Anti-Convulsants, Other Drug Classes
3) By Treatment: Drug Treatment, Radiotherapy, Physiotherapy, Other Treatments
4) By Distribution Channel: Online Distribution, Offline Distribution
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Peripheral Neuropathy: Distal Symmetric Neuropathy, Mononeuropathy, Polyneuropathy
2) By Autonomic Neuropathy: Cardiovascular Autonomic Neuropathy, Gastrointestinal Autonomic Neuropathy, Genitourinary Autonomic Neuropathy
3) By Proximal Neuropathy: Diabetic Amyotrophy, Lumbosacral Plexus Neuropathy
4) By Focal Neuropathy: Cranial Neuropathy, Cervical Radiculopathy, Other Focal Neuropathies
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9057&type=smp
What Key Drivers Are Expected to Influence Future Diabetic Neuropathy Market Growth?
The diabetic neuropathy market is set to benefit from the escalating prevalence of diabetes. The malady of diabetes arises when the body is unable to properly process and store glucose (a form of sugar). This can occur when there is an inadequacy in insulin production- a hormone responsible for blood sugar control- or in instances where insulin is not utilized effectively. Diabetic neuropathy, a nerve damage condition, emerges in those with diabetes, manifesting in different forms and symptoms. A report from the International Diabetes Federation, a Belgium-based conglomerate of over 230 national diabetes associations, revealed in August 2022 through their IDF Diabetes Atlas that diabetes was the causative factor in 6.7 million fatalities in 2021, which translates to a death every five seconds. Statistics show that 537 million adults (within the age bracket of 20-79) or 1 in 10 individuals are currently living with diabetes. Projections illustrate that this figure is expected to rise to 643 million by 2030 and further up to 783 million by 2045. Consequently, the upward trend in diabetes prevalence is fuelling the growth of the diabetic neuropathy market.
Which Companies Hold the Largest Share Across Different Diabetic Neuropathy Market Segments?
Major companies operating in the diabetic neuropathy market include Pfizer Inc., Eli Lilly and Company, Daiichi Sankyo Company Limited, Johnson & Johnson, Depomed Inc., F. Hoffmann-La Roche AG, NeuroMetrix Inc, Lupin Limited, Novartis AG, Boehringer Ingelheim, Regenacy Pharmaceuticals Inc., Merck & Co. Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Merck KGaA, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Zydus Cadila, Biogen Inc., Genentech Inc.
What Trends Are Driving Growth in The Diabetic Neuropathy Market?
Leading firms in the diabetic neuropathy market are pioneering innovative products such as neuromodulation therapy devices to amplify treatment choices for patients struggling with chronic pain linked to diabetic neuropathy. These devices provide non-surgical treatment alternatives by altering nerve activity to alleviate pain, ameliorate nerve function, and aid healing in patients with diabetic nerve injury. For example, Neuralace Medical, Inc., a US-based firm offering non-drug pain management solutions, won approval from the Food and Drug Administration (FDA), a US federal body, for its Axon Therapy for Chronic Painful Diabetic Neuropathy in January 2024. The Axon Therapy device is engineered to treat Chronic Painful Diabetic Neuropathy (CPDN). This ground-breaking therapy applies neuromodulation methods to provide relief from pain related to diabetic neuropathy, signifying a substantial progression in pain management alternatives for patients afflicted with this condition. FDA's approval emphasizes the device's safety and efficiency, enabling Neuralace to proceed with commercialization and widen the reach of effective treatment options for those impacted by CPDN.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report
What Are the Emerging Geographies for The Diabetic Neuropathy Market Growth?
North America was the largest region in the diabetic neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the diabetic neuropathy market during the forecast period. The regions covered in the diabetic neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Diabetic Neuropathy Market?
2. What is the CAGR expected in the Diabetic Neuropathy Market?
3. What Are the Key Innovations Transforming the Diabetic Neuropathy Industry?
4. Which Region Is Leading the Diabetic Neuropathy Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Neuropathy Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here
News-ID: 3977684 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Neuropathy
Morningstar Neuropathy and Pain Treatment Center Offers Advanced Neuropathy Trea …
Morningstar Neuropathy and Pain Treatment Center in St. Peters, MO, introduces advanced restorative protocols for peripheral neuropathy. This non-surgical approach addresses nerve pain and numbness by focusing on microcirculation and cellular repair. Led by Dr. Andrew Morningstar, the clinic provides a drug-free alternative to traditional medications, helping patients reclaim mobility without sedative side effects.
ST. PETERS, MO - April 13, 2026 - Morningstar Neuropathy and Pain Treatment Center [https://morningstarregmed.com/] offers specialized…
Small-Fiber Neuropathy (SFN) Market Poised for Rapid Growth as Demand for Neurop …
The global Small-Fiber Neuropathy (SFN) market is witnessing robust growth, driven by rising diabetic and idiopathic neuropathy prevalence, improved diagnostics, and growing demand for effective therapies. The market is expected to show steady long-term expansion through 2034, signaling strong opportunities for healthcare providers, pharma companies, and investors.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72073
1. Keyword Definition - Small-Fiber Neuropathy (SFN)
Small-Fiber Neuropathy (SFN) is a neurological disorder caused by damage…
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding
WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to…
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market
Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,…
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In …
What industry-specific factors are fueling the growth of the diabetic peripheral neuropathy market?
The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The…
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market?
The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses…
